Sarecycline

Fidelia Bernice, Pharm.D.

INDICATIONS

FDA

  • Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients ≥ 9 years old

NON-FDA APPROVED USES

N/A

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 9, 2019